Cryptococcosis Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025 the global Cryptococcosis market was valued at US$ 4.51 Bn in 2016, and is expected to reach US$ 6.76 Bn by 2025, expanding at a CAGR of 4.5% from 2017 to 2025.
Browse Full Report Visit – http://www.acutemarketreports.com/report/cryptococcosis-market
Cryptococcosis is a potentially fatal fungal disease occurs due to Cryptococcus, major causes of cryptococcosis are infection by neoformans and gattii. Increase in prevalence of fatal fungal disease, availability of advance treatment options and last-stage HIV patients developing the disease are driving the growth of Cryptococcosis market worldwide. For the purpose of study, global Cryptococcosis market is segmented on the basis of treatment type such as Amphotericin B, Flucytosine, Fluconazole and other treatment options. It is observed that, in the base year 2016, Flucytosine was major revenue contributing segment because it generally given as first line treatment in combination with other antifungal medications and higher adherence to Flucytosine treatment are influencing the growth of Flucytosine market worldwide. Cryptococcosis market is currently dominated by North America, United States observed as largest revenue contributor, due to factors such as higher cost of medication, rising incidence of the fungal infections in endemic areas of North America and higher investments in R&D in development of Cryptococcosis medication are driving the market growth in North America. Middle East and Africa expected to show significant market growth during forecast period because higher number of HIV infected patients and increase in demand for cryptococcosis medication would further drive the market growth during forecast period. However, factor such as comparatively lower cost of treatment medication may negatively impact the growth of Cryptococcosis market in Middle East and Africa.
Market Competition Assessment:
The Cryptococcosis market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Abbott Laboratories, Alkopharma Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Glenmark Pharmaceuticals, Janssen Biotech, Inc. (Johnson & Johnson), Novartis AG, Pfizer, Inc., Sigmapharm Laboratories LLC., Valeant Pharmaceuticals, Inc. and other.
Browse All Reports of This Category – http://www.acutemarketreports.com/category/pharmaceutical-market
Key Market Movements:
• Factors such as higher prevalence of cryptococcosis, increase in awareness for treatment, favorable reimbursement policies in some countries and high degree of R&D activity in development of Cryptococcosis medication are driving the growth of cryptococcosis market worldwide.
• Due to the higher number of unmet needs, manufacturers in the market are focusing on innovation and technological advances in treatment options would further influence the market growth of Cryptococcosis market globally.
• However, poor patient compliance to medication in some countries and adverse effects associated with the use of medication would negatively impact the growth of Cryptococcosis market globally.
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
Chapter 2 Executive Summary
2.1 Global Cryptococcosis Market Snapshot
2.2 Global Cryptococcosis Market, by Treatment Type, 2016 (US$ Bn)
2.3 Global Cryptococcosis Market Share, by Geography, 2016 (Value %)
Chapter 3 Cryptococcosis Market Analysis
3.1 Global Cryptococcosis Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
22.214.171.124 Significant Unmet Need
126.96.36.199 High prevalence of Cryptococcosis and other fungal diseases
188.8.131.52 Poor Patient Compliance in some countries
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Cryptococcosis Market
Chapter 4 Global Cryptococcosis Market, by Treatment Type
4.2 Amphotericin B
4.5 Other (Voriconazole, surgery treatment, etc.)
Chapter 5 Global Cryptococcosis Market, By Geography
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.5 Latin America
5.6 Middle East and Africa
To Get Complete Report @ http://www.acutemarketreports.com/report/cryptococcosis-market
Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 Alkopharma Inc.
6.3 Astellas Pharma Inc.
6.4 Bristol-Myers Squibb Company
6.5 Glenmark Pharmaceuticals
6.6 Janssen Biotech, Inc. (a Johnson & Johnson)
6.7 Novartis AG
6.8 Pfizer Inc.
6.9 Sigmapharm Laboratories LLC.
6.10 Valeant Pharmaceuticals, Inc.
Latest Reports :
About – Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Name : Chris Paul
ACUTE MARKET REPORTS
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Email : email@example.com
Website : http://www.acutemarketreports.com
Our Blog :- http://www.pdfdevices.com/